Home Page

Who We Are

The Centre National de Génotypage is situated at the Génopole site in Evry, about 30 km south of Paris, where it has the benefit of a particularly favourable research environment through links with other laboratories on the same site: a campus for genomics research and biotechnology in France.

History of the CNG

The Centre National de Génotypage (CNG) was created as a GIP (Public Interest Group) by the French Ministry of Research and New Technology. In October 1998, the CNG took over the genomic activities of the Généthon, which pioneered genetic studies in France with the support of the French Muscular Dystrophy Association. In 2002, the CNG became part of a new GIP, the Consortium National de Recherche en Génomique or CNRG. In addition to the Ministry, the members of the GIP CNRG are the INSERM (Institut National de la Santé et de la Recherche Médicale), CNRS (Centre National de la Recherche Scientifique), INRA (Institut National de Institut National de la Recherche Agronomique), the CEA (Commissariat à l'Energie Atomique) and FIST (France Innovation Scientifique et Transfert, the technology transfer wing of the CNRS). The CNG integrated into the CEA's (Commissariat à l’Energie Atomique et aux energies Alternative) Life Science division in 2007.

Mission of the center

The main objective of the CNG is to advance research of the genetics of human diseases through internal and collaborative research programs.

To this end the CNG has developed a number of state-of-the-art genomics technology platforms and laboratories. Technology available at CNG ranges from a fully integrated high-throughput genotyping facility to a next generation sequencing platform. Activities include whole genome association studies (GWAS), pan-genomic expression profiling, epigenetic studies (DNA methylation, chromatin structure studies) and whole genome sequencing. All platforms, tools and know-how developed at CNG are open to outside groups for through collaborative research programs, and also applied by the Centre for its own research into the genetic basis of hereditary diseases.


L'appel à propositions est ouvert en continu.